Key result
This review article describes the epidemiology, risk factors, pathophysiology, and current treatment modalities for left ventricular systolic dysfunction related to ischemic heart disease.
This article provides a comprehensive review of the epidemiology, risk factors, pathophysiology, and treatment modalities for left ventricular systolic dysfunction and ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Synthesizes current evidence on ischemic LV systolic dysfunction for clinical reference; leaves open gaps requiring prospective trials on novel therapies.
Coronary artery disease is the primary risk factor for left ventricular systolic dysfunction and the most common cause of heart failure. Heart failure is the prevailing diagnosis for hospital admissions in the United States for people over 65 years of age. It has a great impact on the health care delivery system as a whole for both inpatient and outpatient treatment. A comprehensive understanding of this disease state is paramount for health care providers. This article describes the epidemiology, risk factors, pathophysiology, and current treatment modalities for left ventricular systolic dysfunction related to heart disease.
No takes yet. Share an insight, caveat, or question.
Lisa Henry (2003) conducted a review in Left ventricular systolic dysfunction and ischemic cardiomyopathy. This review article describes the epidemiology, risk factors, pathophysiology, and current treatment modalities for left ventricular systolic dysfunction related to ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: